Previous 10 | Next 10 |
Horizon Therapeutics Public Limited Company (HZNP) Q1 2020 Earnings Conference Call May 06, 2020 08:00 AM ET Company Participants Tina Ventura - Senior Vice President, Investor Relations Tim Walbert - Chairman, President & Chief Executive Officer Liz Thompson - Group Vice Pre...
The following slide deck was published by Horizon Therapeutics Public Limited Company in conjunction with their 2020 Q1 earnings Read more ...
CPS Technologies (NASDAQ: CPSH ) +71% on Q1 results . More news on: CPS Technologies Corporation, Medigus Ltd., Predictive Oncology Inc., Stocks on the move, , Read more ...
Horizon Therapeutics ( HZNP ) Q1 results : More news on: Horizon Therapeutics Public Limited Company, Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Horizon Pharma (NASDAQ: HZNP ): Q1 Non-GAAP EPS of $0.40 beats by $0.19 ; GAAP EPS of -$0.07 beats by $0.07 . More news on: Horizon Therapeutics Public Limited Company, Earnings news and commentary, Healthcare stocks news, Read more ...
-- First-Quarter 2020 Net Sales of $355.9 Million Increased 27 Percent; First-Quarter 2020 GAAP Net Loss of $13.6 Million; Adjusted EBITDA of $107.2 Million -- -- Orphan Segment First-Quarter 2020 Net Sales of $245.4 Million, an Increase of 47 Percent; KRYSTEXXA® First-Quarter 2...
Horizon Pharma (NASDAQ: HZNP ) is scheduled to announce Q1 earnings results on Wednesday, May 6th, before market open. The consensus EPS Estimate is $0.21 (-30.0% Y/Y) and the consensus Revenue Estimate is $287.88M (+2.7% Y/Y). Over the last 2 years, HZNP has beaten EPS estimates 88%...
-- New dosage form in tear-open packets provides a convenient option for people living with cystinosis -- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that PROCYSBI® (cysteamine bitartrate) delayed-release oral granules in packets are now available in the United States ...
Horizon Therapeutics ( HZNP ) is a company that got on my radar earlier this year when their thyroid eye disease treatment, TEPEZZA, received FDA approval 2 months ahead of schedule. The more I’ve researched this biopharma company, the more I like what I see. Horizon’s sales have...
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its first-quarter 2020 financial results will be released on Wednesday, May 6, 2020. Following the announcement, Horizon's management will host a live webcast at 8 a.m. Eastern Time to review the Company's financial and operating re...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Horizon Therapeutics Public Limited Company Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...